Case Report
Accepted on 04 Nov 2025
Case Report: Should IGF-1R Targeted Therapy Be Revisited in Ewing Sarcoma? A Report of Long-term Complete Response and Review of the Literature
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
Type at least 3 characters
2,016 articles
Original Research
Accepted on 04 Nov 2025
Application of Nisin as a Potential Drug Candidate for Electrochemotherapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
Original Research
Accepted on 03 Nov 2025
ZK53 enhances tumor cell susceptibility to ferroptosis via ClpP-mediated mitochondrial dysfunction
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
Opinion
Published on 03 Nov 2025
Targeting PI3Kδ in cancer: a setback or the end
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1614882
- 583 views
Original Research
Accepted on 30 Oct 2025
Pan-cancer analysis reveals ELFN1 as a novel prognostic biomarker and immunotherapeutic target associated with tumor microenvironment remodeling and promoting malignant phenotypes in colorectal cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 475 views
Case Report
Accepted on 30 Oct 2025
Partial Response in a Patient With Skeletal and Hepatic Metastases Following Resected Pancreatic Cancer to the Novel Cell Therapy SL-28: A Case Report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 133 views
Review
Accepted on 30 Oct 2025
Advances in the Study of FOXQ1: Biological Functions and Mechanisms
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
Review
Accepted on 29 Oct 2025
Targeting TEAD in Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
Original Research
Accepted on 28 Oct 2025
Evaluation of Expression Profiles of APOA4, CEACAM1, CD147, DJ-1/PARK7, Gamma-synuclein, S100A1, and Stathmin-1 in Urothelial Carcinomas using Immunohistochemical Assays
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 101 views
Original Research
Accepted on 28 Oct 2025
CldU Sensitizes BRCA2 Reverse-Mutated Cells to PARP Inhibitors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 131 views
Review
Accepted on 28 Oct 2025
CD44 Targeted Functionalized Nanocarriers for Non-Small Cell Lung Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 144 views
Case Report
Accepted on 27 Oct 2025
HER2-Targeted Therapy Combined with Multidisciplinary Management in Advanced Gallbladder Cancer: A Case Report with 90-month Survival
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 133 views
Original Research
Published on 27 Oct 2025
Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1648779
- 586 views
Review
Published on 27 Oct 2025
Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1657441
- 492 views
Review
Published on 27 Oct 2025
PROTAC: a revolutionary technology propelling small molecule drugs into the next golden age
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1676414
- 1,394 views
Original Research
Accepted on 24 Oct 2025
Metformin Enhances Alpelisib Sensitivity in HER2+ Breast Cancer by Suppressing Cancer Stemness and Oncogenic Signaling
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
- 324 views